TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year

Mar.03
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.

Key Takeaways

 

  • March 2, 2026: TPB released highlights from its fiscal 2025 fourth-quarter results;
  • Q4 revenue: $121 million, up 29% year over year;
  • Modern Oral net revenue: $41.3 million, up 266% year over year;
  • Adjusted EBITDA: $30 million, up 14%, with a 24.8% margin;
  • 2026 Modern Oral guidance: gross sales of $220–$240 million; net sales of $180–$190 million.

2Firsts, March 3, 2026

 

According to GuruFocus News, Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, released key highlights from its fiscal 2025 fourth-quarter results. The company said Q4 revenue increased 29% year over year to $121 million.

 

The company reported that adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization, EBITDA) rose 14% year over year to $30 million, representing a 24.8% margin. Gross margin was 55.9%, flat versus the same period last year. Q4 SG&A expenses were $47.7 million, up $3.1 million from the prior quarter.

 

By segment, the Stoker’s segment (including modern nicotine pouches, traditional oral tobacco, and chewing tobacco) posted Q4 net sales of $81 million, up 70% year over year. The Zig-Zag segment (rolling papers) recorded Q4 net sales of $40 million, down 13% year over year. The company said the Modern Oral segment posted Q4 net revenue of $41.3 million, up 266% year over year.

 

On cash flow and capital expenditures, the company reported Q4 free cash flow of $19.2 million. Quarterly capital expenditures (CapEx) were $3.3 million, and ending cash balance was $222.8 million.

 

The company also provided 2026 guidance: Modern Oral gross sales are projected at $220–$240 million, and Modern Oral net sales at $180–$190 million. It also guided for Q1 2026 EBITDA of $24–$27 million. The company further disclosed a forward-looking effective income tax rate range of 23%–26%, and a 2026 CapEx budget of $4–$5 million (excluding Modern Oral projects).

 

Regarding business progress and risk factors, the company said it is expanding its distribution network, with ALP nicotine pouches appearing in brick-and-mortar retail stores ahead of schedule. It also said it will make strategic investments in sales and marketing, including expanding its sales force and improving its online presence. The company noted that ongoing sales and marketing investments make it challenging to accurately forecast EBITDA beyond the first quarter, and warned that potential tax increases on nicotine pouches could affect pricing and promotional strategies. It also said elevated tariff rates have impacted gross margins in the Stoker’s segment.

 

 

Image Source:yahoofinance

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.
Apr.30 by 2FIRSTS.ai
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
Geneva Court Annuls Ban on Disposable E-Cigarette Sales, Says Power Lies With Federal Authorities
The Geneva Court of Justice on Tuesday upheld appeals filed by four associations and companies active in the tobacco trade and annulled the Geneva legal provision banning the sale of disposable e-cigarettes, commonly known as “puffs.”
Apr.30 by 2FIRSTS.ai
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
Haypp Group said ZYN ULTRA became available nationwide in the United States on June 15 through its e-commerce platforms Nicokick.com and Northerner.com for verified adult nicotine consumers.
Jun.17
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea said on April 29 that it has appointed Lee Hong-seok, head of its smoke-free products division, as its new chief executive officer, with his term beginning on May 1. Yoon Hee-kyung, who took office in 2023, will step down after about three years in the role.
Apr.30 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai